Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Journal of Endocrinological Investigation
Erschienen in:

01.06.2019 | Original Article

Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect

verfasst von: S. Fittipaldi, V. M. Bimonte, A. Soricelli, A. Aversa, A. Lenzi, E. A. Greco, S. Migliaccio

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Cadmium (Cd) is a widespread environmental pollutant that causes alterations in human health acting as endocrine disruptor. Recent data suggest that cardiovascular system might be a contamination target tissue, since Cd is found in atheromatic plaques. Thus, the purpose of this study was to evaluate the consequence of Cd exposure of endothelial cells in vitro to evaluate detrimental effect in vascular system by a potential sex-steroid hormone receptor-dependent mechanism(s).

Methods

To this aim, Human Umbilical Vein Endothelial Cells (HUVECs) were cultured and exposed to several concentrations of cadmium chloride (CdCl2) for different interval times.

Results

CdCl2 exposure of HUVECs induced a significant increase of ERβ and Cyp19a1 at both mRNA and protein levels, while a drastic dose-dependent decrease of AR expression level was observed after 24 h of exposure. On the contrary, an increase of PhARser308 as well as a reduction of PhGSK-3βser9 and PhAKTser473 was detected after 1 h treatment. This effect was consistently reduced by GSK inhibition. Furthermore, CdCl2 abolished DHT-induced cell proliferation in HUVECs suggesting an antagonist-like effect of Cd on AR-mediated signaling. Remarkable, after 6 h CdCl2—treatment, a relevant increase in TNF-α, IL-6 and IL-8 mRNA was observed and this effect was blocked by the presence of an ERβ-selective antagonist. Moreover, Cd-induced TxR1 overexpression, likely, correlated with the activation of p38 MAPK/NF-κB pathway.

Conclusion

In conclusion, our study demonstrates for the first time that Cd alters sex-steroid hormone receptors level and activity likely affecting intracellular signaling linked to a proinflammatory state in endothelial cells. This alteration might possibly lead to endothelial cell injury and vascular dysfunction and could be a mechanism of gender-specific atherogenic damages induced by endocrine disruptors and, thus, induce atherogenic events with increased risk of cardiovascular diseases in individuals exposed to this endocrine disruptor.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ (2012) Heavy metals toxicity and the environment. EXS 101:133–164PubMedPubMedCentral
2.
Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G, Mariani S, Cherubini S, Scotto d’Abusco A, Scandurra R, Migliaccio S (2007) Cadmium induces mitogenic signaling in breast cancer cell by an ERβ-dependent mechanism. Mol Cell Endocrinol 264(1–2):102–108CrossRefPubMed
3.
World Health Organization (2011) Evaluation of certain food additive and contaminants. World Health Organ Tech Rep Ser 960:1–226
4.
EFSA (2011) Statement on tolerable weekly intake for cadmium Efsa panel on contaminants in the food chain (CONTAM). EFSA J 9:1975
5.
Mortada WI, Sobh MA, El Defrawy MM (2004) Lead and mercury from smoking and its impact on renal integrity. Med Sci Monit 10:CR112–CR116PubMed
6.
Thévenod F, Lee WK (2013) Cadmium and cellular signaling cascades: interactions between cell death and survival pathways. Arch Toxicol 87(10):1743–1786CrossRefPubMed
7.
Papa V, Wannenes F, Crescioli C, Caporossi D, Lenzi A, Migliaccio S, Di Luigi L (2014) The environmental pollutant cadmium induces homeostasis alteration in muscle cells in vitro. J Endocrinol Invest 37(11):1073–1080CrossRefPubMed
8.
Papa V, Bimonte VM, Wannenes F, D’Abusco AS, Fittipaldi S, Scandurra R, Politi L, Crescioli C, Lenzi A, Di Luigi L, Migliaccio S (2015) The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases. J Endocrinol Invest 38(12):1345–1356CrossRefPubMed
9.
Samarghandian S, Azimi-Nezhad M, Shabestari MM, Azad FJ, Farkhondeh T, Bafandeh F (2015) Effect of chronic exposure to cadmium on serum lipid, lipoprotein and oxidative stress indices in male rats. Interdiscip Toxicol 8(3):151–154CrossRefPubMedPubMedCentral
10.
Amzal B, Julin B, Vahter M, Wolk A, Johanson G, Akesson A (2009) Population toxicokinetic modeling of cadmium for health risk assessment. Environ Health Perspect 117(8):1293–1301CrossRefPubMedPubMedCentral
11.
Satarug S, Garrett SH, Sens MA, Sens DA (2010) Cadmium, environmental exposure, and health outcomes. Environ Health Perspect 118(2):182–190CrossRefPubMed
12.
13.
Messner B, Knoflach M, Seubert A, Ritsch A, Pfaller K, Hen-derson B, Shen YH, Zeller I, Willeit J, Laufer G, Wick G, Kiechl S, Bernhard D (2009) Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 29(9):1392–1398CrossRefPubMed
14.
Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A (2013) Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep 15(10):356CrossRefPubMed
15.
Almenara CC, Broseghini-Filho GB, Vescovi MV, Angeli JK, Faria Tde O, Stefanon I, Vassallo DV, Padilha AS (2013) Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta. PLoS One 8(7):e68418CrossRefPubMedPubMedCentral
16.
Angeli JK, Cruz Pereira CA, de Oliveira Faria T, Stefanon I, Padilha AS, Vassallo DV (2013) Cadmium exposure induces vascular injury due to endothelial oxidative stress: the role of local angiotensin II and COX-2. Free Radic Biol Med 65:838–848CrossRefPubMed
17.
18.
Tinkov AA, Filippini T, Ajsuvakova OP, Skalnaya MG, Aaseth J, Bjørklund G, Gatiatulina ER, Popova EV, Nemereshina ON, Huang PT, Vinceti M, Skalny AV (2018) Cadmium and atherosclerosis: a review of toxicological mechanisms and a meta-analysis of epidemiologic studies. Environ Res 162:240–260CrossRefPubMed
19.
Hecht EM, Arheart KL, Lee DJ, Hennekens CH, Hlaing WM (2016) Interrelation of cadmium, smoking, and cardiovascular disease (from the National Health and Nutrition Examination Survey). Am J Cardiol 118(2):204–209CrossRefPubMed
20.
Wei T, Jia J, Wada Y, Kapron CM, Liu J (2017) Dose dependent effects of cadmium on tumor angiogenesis. Oncotarget 8(27):44944–44959PubMedPubMedCentral
21.
Prozialeck WC, Edwards JR, Woods JM (2006) The vascular endothelium as a target of cadmium toxicity. Life Sci 79(16):1493–1506CrossRefPubMed
22.
23.
Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB (1994) Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269(24):16896–16901PubMed
24.
Stoica A, Katzenellenbogen BS, Martin MB (2000) Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 14(4):545–553PubMed
25.
Martin MB, Voeller HJ, Gelmann EP, Lu J, Stoica EG, Hebert EJ, Reiter R, Singh B, Danielsen M, Pentecost E, Stoica A (2002) Role of cadmium in the regulation of AR gene expression and activity. Endocrinology 143(1):263–275CrossRefPubMed
26.
Aquino NB, Sevigny MB, Sabangan J, Louie MC (2012) The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not? J Environ Sci Health C 30(3):189–224CrossRef
27.
Wu R, Cui Y, Yuan X, Yuan H, Wang Y, He J, Zhao J, Peng S (2014) SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation. Toxicol Lett 229(2):405–413CrossRefPubMed
28.
Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC (2010) Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERβ and c-Jun. Mol Endocrinol 24(5):981–989CrossRefPubMedPubMedCentral
29.
Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB (2003) Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9(8):1081–1084CrossRefPubMed
30.
Nishijo M, Satarug S, Honda R, Tsuritani I, Aoshima K (2004) The gender differences in health effects of environmental cadmium exposure and potential mechanisms. Mol Cell Biochem 255(1–2):87–92CrossRefPubMed
31.
Pillet S, D’Elia M, Bernier J, Bouquegneau JM, Fournier M, Cyr DG (2006) Immunomodulatory effects of estradiol and cadmium in adult female rats. Toxicol Sci 92(2):423–432CrossRefPubMed
32.
Barregard L, Sallsten G, Fagerberg B, Borné Y, Persson M, Hedblad B, Engström G (2016) Blood cadmium levels and incident cardiovascular events during follow-up in a population-based cohort of Swedish adults: the Malmö Diet and Cancer Study. Environ Health Perspect 124(5):594–600CrossRefPubMed
33.
Cheng L, Zhang B, Zheng T, Hu J, Zhou A, Bassig BA, Xia W, Savitz DA, Buka S, Xiong C, Braun JM, Zhang Y, Zhou Y, Pan X, Wu C, Wang Y, Qian Z, Yang A, Romano ME, Shi K, Xu S, Li Y (2017) Critical windows of prenatal exposure to cadmium and size at birth. Int J Environ Res Public Health 14(1):58CrossRefPubMedCentral
34.
Koryakina Y, Ta HQ, Gioeli D (2014) Androgen receptor phosphorylation: biological context and functional consequences. Endocr Relat Cancer 21(4):T131–T145CrossRefPubMedPubMedCentral
35.
Zong H, Chi Y, Wang Y, Yang Y, Zhang L, Chen H, Jiang J, Li Z, Hong Y, Wang H, Yun X, Gu J (2007) Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Mol Cell Biol 27(20):7125–7142CrossRefPubMedPubMedCentral
36.
Salas TR, Kim J, Vakar-Lopez F, Sabichi AL, Troncoso P, Jenster G, Kikuchi A, Chen SY, Shemshedini L, Suraokar M, Logothetis CJ, DiGiovanni J, Lippman SM, Menter DG (2004) Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem 279(18):19191–19200CrossRefPubMed
37.
Cai J, Hong Y, Weng C, Tan C, Imperato-McGinley J, Zhu YS (2011) Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Am J Physiol Heart Circ Physiol 300(4):H1210–H1221CrossRefPubMedPubMedCentral
38.
Colacino JA, Arthur AE, Ferguson KK, Rozek LS (2014) Dietary antioxidant and anti-inflammatory intake modifies the effect of cadmium exposure on markers of systemic inflammation and oxidative stress. Environ Res 131:6–12CrossRefPubMedPubMedCentral
39.
Dong F, Guo F, Li L, Guo L, Hou Y, Hao E, Yan S, Allen TD, Liu J (2014) Cadmium induces vascular permeability via activation of the p38 MAPK pathway. Biochem Biophys Res Commun 450(1):447–452CrossRefPubMed
40.
Olszowski T, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2012) Pro-inflammatory properties of cadmium. Acta Biochim Pol 59(4):475–482CrossRefPubMed
41.
Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, Ono M (2004) Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 18(2):300–310CrossRefPubMed
42.
Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M, Hara S (2005) Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. al cells: role of NF-E2-related factor-2. J Cell Physiol 203(3):529–537CrossRefPubMed
43.
Torres-Estay V, Carreño DV, San Francisco IF, Sotomayor P, Godoy AS, Smith GJ (2015) Androgen receptor in human endothelial cells. J Endocrinol 224(3):R131–R137CrossRefPubMedPubMedCentral
44.
Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li L, Yeh S, Chang C (2013) Endothelial cells enhance prostate cancer metastasis via IL-6 → androgen receptor → TGF-β → MMP-9 signals. Mol Cancer Ther 12(6):1026–1037CrossRefPubMedPubMedCentral
45.
Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K (2005) Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res 96(3):308–318CrossRefPubMed
46.
Eto M, Kouroedov A, Cosentino F, Lüscher TF (2005) Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-alpha. Circulation 112(9):1316–1322CrossRefPubMed
47.
Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32(4–5):577–595CrossRefPubMed
48.
Kim S, Cheon H, Kim SM, Kim YY (2018) GSK-3β-mediated regulation of cadmium-induced cell death and survival. Cell Mol Biol Lett 12(23):9CrossRef
49.
Kim J, Lim W, Ko Y, Kwon H, Kim S, Kim O, Park G, Choi H, Kim O (2012) The effects of cadmium on VEGF-mediated angiogenesis in HUVECs. J Appl Toxicol 32(5):342–349CrossRefPubMed
50.
Nair AR, DeGheselle O, Smeets K, Van Kerkhove E, Cuypers A (2013) Cadmium-induced pathologies: where is the oxidative balance lost (or not)? Int J Mol Sci 14(3):6116–6143CrossRefPubMedPubMedCentral
51.
Go Y-M, Orr M, Jones DP (2013) Increased nuclear thioredoxin-1 potentiates cadmium-induced cytotoxicity. Toxicol Sci 131(1):84–94CrossRefPubMed
52.
Sandbichler AM, Höckner M (2016) Cadmium protection strategies—a hidden trade-off? Int J Mol Sci 7(1):139CrossRef
53.
Valko M, Morris H, Cronin MT (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12(10):1161–1208CrossRefPubMed
54.
Cuypers A, Plusquin M, Remans T, Jozefczak M, Keunen E, Gielen H, Opdenakker K, Nair AR, Munters E, Artois TJ, Nawrot T, Vangronsveld J, Smeets K (2010) Cadmium stress: an oxidative challenge. Biometals 23(5):927–940CrossRefPubMed
55.
Nemmiche S (2017) Oxidative signaling response to cadmium exposure. Toxicol Sci 156(1):4–10PubMed
56.
Wolf MB, Baynes JW (2007) Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals 20(1):73–81CrossRefPubMed
57.
Knoflach M, Messner B, Shen YH, Frotschnig S, Liu G, Pfaller K, Wang X, Matosevic B, Willeit J, Kiechl S, Laufer G, Bernhard D (2011) Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ J 75(10):2491–2495CrossRefPubMed
58.
Sakurai A, Yuasa K, Shoji Y, Himeno S, Tsujimoto M, Kunimoto M, Imura N, Hara S (2004) Overexpression of thioredoxin reductase 1 regulates NF-kappa B activation. J Cell Physiol 198(1):22–30CrossRefPubMed
59.
Zhou Z, Lu YH, Pi HF, Gao P, Li M, Zhang L, Pei LP, Mei X, Liu L, Zhao Q, Qin QZ, Chen Y, Jiang YM, Zhang ZH, Yu ZP (2016) Cadmium exposure is associated with the prevalence of dyslipidemia. Cell Physiol Biochem 40(3–4):633–643CrossRefPubMed
60.
Seok SM, Park DH, Kim YC, Moon CH, Jung YS, Baik EJ, Moon CK, Lee SH (2006) COX-2 is associated with cadmium-induced ICAM-1 expression in cerebrovascular endothelial cells. Toxicol Lett 165(3):212–220CrossRefPubMed
61.
Park SL, Kim YM, Ahn JH, Lee SH, Baik EJ, Moon CH, Jung YS (2009) Cadmium stimulates the expression of vascular cell adhesion molecule-1 (VCAM-1) via p38 mitogen-activated protein kinase (MAPK) and JNK activation in cerebrovascular endothelial cells. J Pharmacol Sci 110(3):405–409CrossRefPubMed
62.
Fagerberg B, Borné Y, Barregard L, Sallsten G, Forsgard N, Hedblad B, Persson M, Engström G (2017) Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease. Environ Res 152:185–191CrossRefPubMed
63.
Szuster-Ciesielska A, Lokaj I, Kandefer-Szerszeń M (2000) The influence of cadmium and zinc ions on the interferon and tumor necrosis factor production in bovine aorta endothelial cells. Toxicology 145(2–3):135–145CrossRefPubMed
64.
Riemschneider S, Herzberg M, Lehmann J (2015) Subtoxic doses of cadmium modulate inflammatory properties of murine RAW 264.7 macrophages. Biomed Res Int 2015:295303CrossRefPubMedPubMedCentral
65.
Phuagkhaopong S, Ospondpant D, Kasemsuk T, Sibmooh N, Soodvilai S, Power C, Vivithanaporn P (2017) Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB pathways. Neurotoxicology 60:82–91CrossRefPubMed
66.
Syeda F, Grosjean J, Houliston RA, Keogh RJ, Carter TD, Paleolog E, Wheeler-Jones CP (2006) Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. J Biol Chem 281(17):11792–11804CrossRefPubMed
67.
Kempe S, Kestler H, Lasar A, Wirth T (2005) NF-kappaB controls the globalpro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res 33(16):5308–5319CrossRefPubMedPubMedCentral
68.
Saha RN, Jana M, Pahan K (2007) MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J Immunol 179(10):7101–7109CrossRefPubMedPubMedCentral
Metadaten
Titel
Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect
verfasst von
S. Fittipaldi
V. M. Bimonte
A. Soricelli
A. Aversa
A. Lenzi
E. A. Greco
S. Migliaccio
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 6/2019
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-018-0982-1

Weitere Artikel der Ausgabe 6/2019

Relevance of TSH evaluation in elderly in-patients with non-thyroidal illness

  • Original Article

Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine

  • Original Article

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1

  • Original Article

Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case–control study in an Italian cohort

  • Original Article

Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus

  • Original Article

Correction to: Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect

  • Correction

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Studie zur HIFU bei Prostatakrebs lässt viele Fragen offen

Führt eine HIFU-Ablation beim Prostatakarzinom im Vergleich mit einer radikalen Prostatektomie zu ähnlichen onkologischen, aber besseren funktionalen Ergebnissen? Interimsdaten der französischen HIFI-Studie sind uneindeutig. In einem Kommentar zur Studie werden zumindest drei allgemeine Erkenntnisse herausgearbeitet.

Leitlinienkonformes Management thermischer Verletzungen

Thermische Verletzungen gehören zu den schwerwiegendsten Traumen und hinterlassen oft langfristige körperliche und psychische Spuren. Die aktuelle S2k-Leitlinie „Behandlung thermischer Verletzungen im Kindesalter (Verbrennung, Verbrühung)“ bietet eine strukturierte Übersicht über das empfohlene Vorgehen.

Verschlechtert frühe Hyperoxie nach Reanimation die Prognose?

Kommt es sehr früh nach einer kardiopulmonalen Reanimation zu einem Zustand der Hyperoxie, ist dies bei Patienten nach einem Herzstillstand mit schlechteren funktionellen Ergebnissen assoziiert. Das zeigt eine Sekundäranalyse der TTM-2-Studie.

Infektanfälligkeit in früher Kindheit: eine bleibende Last?

Wenn Kinder in den ersten Lebensjahren immer wieder Infekte durchmachen, lässt dies Schlüsse auf die Infektneigung in der weiteren Kindheit zu.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise